genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
BioPerspectives
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
News
Broccoli Ingredient Suppresses Tumor Growth in Cancer Mouse Model
Neuroscience
Huntington’s Disease Gets New Onset Age Predictor
Genetics
Our Genes Have a Major Influence on Whether We Choose to…
News
Over 99% of CTCs Captured on New Microfluidic Chip
News
Genentech, Parvus Therapeutics Launch Up-to-$800M Autoimmune Collaboration
Insights
Tech Exclusives
Rising to the Challenge of Intensifying Bioprocesses
May 2019 Vol. 39 No. 5
A Scalable Adenovirus Production Process from Cell Culture to Purified Bulk…
May 2019 Vol. 39 No. 5
Genomics’ “Green” Future
Tech Exclusives
Microbial Culture Systems for Bioprocessing
Insights
Phage Therapy Win: Mycobacterium Infection Halted
A-Lists
A-Lists
Top 10 Under 40 of 2019
Insights
Top 10 Best-Selling Cancer Drugs of 2018
Insights
Top 10 Sequencing Companies
May 2019 Vol. 39 No. 5
Top 10 Immuno-Oncology Collaborations
A-Lists
Top 15 Best-Selling Drugs of 2018
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
News
Broccoli Ingredient Suppresses Tumor Growth in Cancer Mouse Model
Genetics
Our Genes Have a Major Influence on Whether We Choose to…
News
Over 99% of CTCs Captured on New Microfluidic Chip
News
Genentech, Parvus Therapeutics Launch Up-to-$800M Autoimmune Collaboration
Magazine
May 2019 Vol. 39 No. 5
A Scalable Adenovirus Production Process from Cell Culture to Purified Bulk…
May 2019 Vol. 39 No. 5
Genomics’ “Green” Future
May 2019 Vol. 39 No. 5
Crafting a More Efficient CAR T-Cell Industry
May 2019 Vol. 39 No. 5
All About That Base Editing
May 2019 Vol. 39 No. 5
Signs, Portents, and Immuno-Oncology Biomarkers
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
BioPerspectives
Podcasts
GENcast: Explore, Learn, and Collaborate on Viral Safety in Biomanufacturing
May 2019 Vol. 39 No. 5
A Scalable Adenovirus Production Process from Cell Culture to Purified Bulk…
Upcoming Webinars
Recent Advances and the Future of Antibody Engineering
Videos
3D Bioprinted Organ Just Took Its First “Breath”
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Home
Companies
Abbvie
Abbvie
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Abbvie
AbbVie, Voyager Launch $1.5B+ Gene Therapy Collaboration Aimed at Parkinson’s, Other Synucleinopathies
Abbvie
AbbVie to Co-Develop Teneobio’s Lead Candidate for Multiple Myeloma, Gains Acquisition Option
Abbvie
FDA Approves First Non-Chemo Combination Therapy for a Form of Leukemia
Abbvie
AbbVie, Lupin to Develop MALT1 Inhibitors for Blood Cancers in $977M+ Partnership
Abbvie
AbbVie Takes Control of Cystic Fibrosis Collaboration with Galapagos
Abbvie
AbbVie, Alphabet-Backed Calico Extend Aging Collaboration by $1B, Three Years
Abbvie
Ablynx, Protagonist Report Phase II Failures
Abbvie
Biogen, AbbVie Withdraw MS Drug Zinbryta after Brain Disorders Spark EMA...
Abbvie
AbbVie, Voyager Launch Up-to-$1.1B+ Gene-Therapy Collaboration to Treat Alzheimer’s, Neurodegenerative Diseases
Abbvie
Regeneron to Lead $50M Exome Sequencing Consortium with UK Biobank
Abbvie
AbbVie Launches, Biogen Tweaks Alzheimer’s Collaborations
Abbvie
AbbVie Gains Options for Up to Three Turnstone Cancer Viral Immunotherapies
Abbvie
Amgen Delaying U.S. Launch of Humira Biosimilar in Settlement with AbbVie
Abbvie
CytomX Wins $15M Milestone Payment from AbbVie for Cancer Probody–Drug Conjugate
Abbvie
AbbVie’s Veliparib Fails in Two Phase III Cancer Combination Therapy Studies
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
